Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide the necessary data and experience to design a larger,
full scale clinical trial to determine if a certain medicine (repaglinide), which increases
the amount of insulin secreted by the pancreas, can improve the nutritional status and
pulmonary function of adolescents and young adults with cystic fibrosis and prediabetes by
improving blood glucose control. The investigators are also trying to determine the
relationship between systemic inflammatory factors and glucose impairment.
Phase:
N/A
Details
Lead Sponsor:
Arbelaez, Ana Maria
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health (NIH) Novo Nordisk A/S Washington University School of Medicine